These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 6574695)

  • 21. Progabide in the treatment of hyperkinetic extrapyramidal movement disorders.
    Mondrup K; Dupont E; Braendgaard H
    Acta Neurol Scand; 1985 Sep; 72(3):341-3. PubMed ID: 3864333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutical approach to involuntary movements (author's transl)].
    Allain H; Sabouraud O
    Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs.
    Ondo WG; Jong D; Davis A
    J Child Neurol; 2008 Apr; 23(4):435-7. PubMed ID: 18192650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholinergizing treatment in hyperkinesis].
    Domzał T
    Neurol Neurochir Pol; 1978; 12(3):257-61. PubMed ID: 150548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Jankovic J; Clarence-Smith K
    Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine depleters in the treatment of hyperkinetic movement disorders.
    Jankovic J
    Expert Opin Pharmacother; 2016 Dec; 17(18):2461-2470. PubMed ID: 27819145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How best to address these common movement disorders.
    Yaman A; Akdeniz M; Yaman H
    J Fam Pract; 2011 Dec; 60(12):721-5. PubMed ID: 22163354
    [No Abstract]   [Full Text] [Related]  

  • 29. Pelvic dyskinesia with an outstanding response to tetrabenazine.
    Alentorn A; Palasí A; Campdelacreu J; Bruna J; Calopa M; Rubio F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):847-8. PubMed ID: 19348867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hyperkinetic movement disorders.
    Bressman SB; Greene PE
    Neurol Clin; 1990 Feb; 8(1):51-75. PubMed ID: 2181268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
    Destee A
    LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic principles in hyperkinetic syndromes].
    Arzumanian AM; Stupa MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(5):32-5. PubMed ID: 7900448
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tetrabenazine in the treatment of late dyskinesias].
    Sepcić J; Ledić P; Antoncić N; Milohanović S; Haasz A; Rudes J
    Neurologija; 1977; 25(1-2):91-3. PubMed ID: 616878
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the therapeutic use of amantadine hydrochloride in non-parkinsonian hyperkinetic syndromes].
    Borromei A
    Minerva Med; 1971 Oct; 62(82):4024-6. PubMed ID: 5125071
    [No Abstract]   [Full Text] [Related]  

  • 35. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol.
    Ondo WG; Hanna PA; Jankovic J
    Am J Psychiatry; 1999 Aug; 156(8):1279-81. PubMed ID: 10450276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG; Breden EL
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case studies in movement disorders.
    Evidente VG; Caviness JN; Adler CH
    Semin Neurol; 2003 Sep; 23(3):277-84. PubMed ID: 14722823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha methylparatyrosine and tetrabenazine in movement disorders.
    Lang AE; Marsden CD
    Clin Neuropharmacol; 1982 Dec; 5(4):375-87. PubMed ID: 6130839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrabenazine.
    Fasano A; Bentivoglio AR
    Expert Opin Pharmacother; 2009 Dec; 10(17):2883-96. PubMed ID: 19929707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.